Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Synthesis and characterization of potent and selective cell permeable inhibitors of poly(ADP-ribose) glycohydrolase

D. Coyle, H. Kim, E. Jacobson, M. Jacobson

Med Sci Monit 2003; 9(1): 17- :: ID: 15064


Adenosine diphosphate (hydroxymethyl)pyrrolidinediol (ADP-HPD) has been shown to be a potent and specific inhibitor of poly(ADP-ribose) glycohydrolase (PARG) [1]. While ADP-HPD inhibits PARG in vitro with an IC50 of approximately 0.2 KM, it is not bioavailable to intact cells due to its highly polar nature. Thus, we have synthesized a number of derivatives of ADP-HPD and evaluated their potency as PARG inhibitors in vitro and their ability to inhibit PARG in cells. Previous studies have shown that substitutions at the 2 position of the adenine ring greatly reduces the potency of ADP-HPD, thus a number of lipophilic derivatives at positions 8 and N6 of the adenine ring were synthesized for evaluation. Modifications at N6 resulted in an unacceptable loss of potency. Modifications at position 8 showed that addition of very bulk groups resulted in greatly diminished potency but a number of lipophilic groups retained good potency. For example, 8-octylamino-ADP-HPD (OA-ADP-HPD) inhibits PARG in vitro with an IC50 of approximately 1.0 KM. The ability of OA-ADP-HPD to inhibit PARG in cells was examined demonstrated by increased ADP-ribose polymer accumulation in MCF-7 cells following genotoxic stress. The effects of inhibition of PARG on ADP-ribose polymer metabolism and biological responses to genotoxic stress will be reported. Cell permeable analogs of ADP-HPD should be useful pharmacological tools to study ADP-ribose polymer metabolism and they have the potential to be useful therapeutic agents.References: 1.Slama et al: J Med Chem, 1995; 38: 389-393

Keywords: Poly(ADP-ribose) glycohydrolase, PARG, PARG inhibitors

Add Comment 0 Comments

218 0


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750